Journal of Acquired Immune Deficiency Syndromes
-
Publication Venue For
-
Brief Report: Kidney Dysfunction Does Not Contribute Significantly to Antiretroviral Therapy Modification in Treatment-Naive PLWH Receiving Initial ART..
81:e6-e9.
2019
-
Integrated Treatment for Smoking Cessation, Anxiety, and Depressed Mood in People Living With HIV: A Randomized Controlled Trial..
79:261-268.
2018
-
Retention in HIV Care During Pregnancy and the Postpartum Period in the Option B+ Era: Systematic Review and Meta-Analysis of Studies in Africa..
77:427-438.
2018
-
Brief Report: Frequency of Monitoring Kidney Function in HIV-Uninfected Persons Using Daily Oral Tenofovir Disoproxil Fumarate Pre-exposure Prophylaxis..
77:206-211.
2018
-
Frequency of Monitoring Kidney Function in HIV-Uninfected Persons Using Daily Oral Tenofovir Disoproxil Fumarate Pre-exposure Prophylaxis.
77:206-211.
2018
-
Partnerships Between a University-Affiliated Clinic and Community-Based Organizations to Reach Black Men Who Have Sex With Men for PrEP Care..
77:e25-e27.
2018
-
HIV Preexposure Prophylaxis Implementation at Local Health Departments: A Statewide Assessment of Activities and Barriers..
77:72-77.
2018
-
The Relationship Between Efavirenz as Initial Antiretroviral Therapy and Suicidal Thoughts Among HIV-Infected Adults in Routine Care..
76:402-408.
2017
-
Social Network Clustering and the Spread of HIV/AIDS Among Persons Who Inject Drugs in 2 Cities in the Philippines..
76:26-32.
2017
-
The Impact of Couple HIV Testing and Counseling on Consistent Condom Use Among Pregnant Women and Their Male Partners: An Observational Study..
75:417-425.
2017
-
Brief Report: Antibody Responses to Quadrivalent HPV Vaccination in HIV-Infected Young Women as Measured by Total IgG and Competitive Luminex Immunoassay..
75:241-245.
2017
-
PMTCT Option B+ Does Not Increase Preterm Birth Risk and May Prevent Extreme Prematurity: A Retrospective Cohort Study in Malawi..
74:367-374.
2017
-
Illness Perceptions, Medication Beliefs, and Adherence to Antiretrovirals and Medications for Comorbidities in Adults With HIV Infection and Hypertension or Chronic Kidney Disease..
73:403-410.
2016
-
Complications and Route of Delivery in a Large Cohort Study of HIV-1-Infected Women-IMPAACT P1025..
73:74-82.
2016
-
Plasma and Intracellular Concentrations in HIV-Infected Patients Requiring Hemodialysis Dosed With Tenofovir Disoproxil Fumarate and Emtricitabine..
73:e8-e10.
2016
-
Brief Report: Macrophage Activation in HIV-Infected Adolescent Males Contributes to Differential Bone Loss by Sex: Adolescent Trials Network Study 021..
72:372-375.
2016
-
Characteristics of Age-Discordant Partnerships Associated With HIV Risk Among Young South African Women (HPTN 068)..
72:423-429.
2016
-
High-Frequency Illegitimate Strand Transfers of Nascent DNA Fragments During Reverse Transcription Result in Defective Retrovirus Genomes..
72:353-362.
2016
-
Dendritic Cell Immunotherapy for HIV-1 Infection Using Autologous HIV-1 RNA: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial..
72:31-38.
2016
-
Elevations in Serum Creatinine With Tenofovir-Based HIV Pre-Exposure Prophylaxis: A Meta-Analysis of Randomized Placebo-Controlled Trials..
71:e115-e118.
2016
-
Participants' Explanations for Nonadherence in the FEM-PrEP Clinical Trial..
71:452-461.
2016
-
Reversibility of Glomerular Renal Function Decline in HIV-Uninfected Men and Women Discontinuing Emtricitabine-Tenofovir Disoproxil Fumarate Pre-Exposure Prophylaxis..
71:374-380.
2016
-
Effect of Depot Medoxyprogesterone Acetate on Immune Functions and Inflammatory Markers of HIV-Infected Women..
71:137-145.
2016
-
HIV-1 Drug Resistance and Second-Line Treatment in Children Randomized to Switch at Low Versus Higher RNA Thresholds..
70:42-53.
2015
-
Comprehensive Characterization of the Transmitted/Founder env Genes From a Single MSM Cohort in China..
69:403-412.
2015
-
Outcomes Up to 12 Months After Treatment With Loop Electrosurgical Excision Procedure for Cervical Intraepithelial Neoplasia Among HIV-Infected Women..
69:200-205.
2015
-
Immune Reconstitution but Persistent Activation After 48 Weeks of Antiretroviral Therapy in Youth With Pre-Therapy CD4 >350 in ATN 061..
69:52-60.
2015
-
The science of being a study participant: FEM-PrEP participants' explanations for overreporting adherence to the study pills and for the whereabouts of unused pills..
68:578-584.
2015
-
Innate activation of MDC and NK cells in high-risk HIV-1-exposed seronegative IV-drug users who share needles when compared with low-risk nonsharing IV-drug user controls..
68:264-273.
2015
-
Traumatic stress and the mediating role of alcohol use on HIV-related sexual risk behavior: results from a longitudinal cohort of South African women who attend alcohol-serving venues..
68:322-328.
2015
-
Traumatic stress and the mediating role of alcohol use on HIV-related sexual risk behavior: Results from a longitudinal cohort of South African women who attend alcohol-serving venues.
68:322-328.
2015
-
Perception of HIV risk and adherence to a daily, investigational pill for HIV prevention in FEM-PrEP..
67:555-563.
2014
-
Changes in proteinuria and albuminuria with initiation of antiretroviral therapy: data from a randomized trial comparing tenofovir disoproxil fumarate/emtricitabine versus abacavir/lamivudine..
67:36-44.
2014
-
HIV and noncommunicable cardiovascular and pulmonary diseases in low- and middle-income countries in the ART era: what we know and best directions for future research..
67 Suppl 1:S40-S53.
2014
-
FEM-PrEP: adherence patterns and factors associated with adherence to a daily oral study product for pre-exposure prophylaxis..
66:324-331.
2014
-
Factors associated with recurrence of cervical intraepithelial neoplasia 2+ after treatment among HIV-infected women in Western Kenya..
66:188-192.
2014
-
World Health Organization's stage 4 conditions among adults accessing outpatient HIV care: a retrospective cohort study in Kisumu, Kenya..
65:e152-e155.
2014
-
Postpartum depression and HIV infection among women in Malawi..
65:359-365.
2014
-
Reduced adherence to antiretroviral therapy among HIV-infected Tanzanians seeking cure from the Loliondo healer..
65:e104-e109.
2014
-
Postpartum depression and HIV infection among women in Malawi.
65:359-365.
2014
-
Cost-effectiveness of newer antiretroviral drugs in treatment-experienced patients with multidrug-resistant HIV disease..
64:382-391.
2013
-
Infant growth outcomes after maternal tenofovir disoproxil fumarate use during pregnancy..
64:374-381.
2013
-
Antiretroviral therapy initiated during acute HIV infection fails to prevent persistent T-cell activation..
62:505-508.
2013
-
Associations between HLA-DRB1*0102, HLA-B*5801, and hepatotoxicity during initiation of nevirapine-containing regimens in South Africa..
62:e55-e57.
2013
-
Performance of creatinine and cystatin C GFR estimating equations in an HIV-positive population on antiretrovirals..
61:302-309.
2012
-
Comorbid diabetes and the risk of progressive chronic kidney disease in HIV-infected adults: data from the Veterans Aging Cohort Study..
60:393-399.
2012
-
Association Between Missed Early Visits and Mortality Among Patients of China National Free Antiretroviral Treatment Cohort.
60:59-67.
2012
-
116 Autologous and Heterologous Neutralizing Antibody Responses in HIV-1 Infection.
59:47-47.
2012
-
Childhood trauma and health outcomes in HIV-infected patients: an exploration of causal pathways..
59:409-416.
2012
-
HIV/HCV-coinfected natural viral suppressors have better virologic responses to PEG-IFN and ribavirin than ARV-treated HIV/HCV patients..
58:e38-e40.
2011
-
Willingness to participate in biomedical HIV prevention studies after the HVTN 503/Phambili trial: a survey conducted among adolescents in Soweto, South Africa..
58:211-218.
2011
-
Mental health and HIV sexual risk behavior among patrons of alcohol serving venues in Cape Town, South Africa..
57:230-237.
2011
-
Factors associated with decreased kidney function in HIV-infected adults enrolled in the MTCT-Plus Initiative in sub-Saharan Africa..
57:40-45.
2011
-
A cost-effectiveness analysis of alternative HIV retesting strategies in sub-saharan Africa..
56:443-452.
2011
-
Hepatitis B vaccination in HIV-infected youth: a randomized trial of three regimens..
56:325-332.
2011
-
Risk factors influencing antibody responses to Kaposi's sarcoma-associated herpesvirus latent and lytic antigens in patients under antiretroviral therapy..
56:83-90.
2011
-
Acute Dengue fever causes false-positive reactivity in OraQuick rapid HIV-1/2 antibody test..
55:641.
2010
-
Erratum: Effects of a coping intervention on transmission risk behavior among people living with HIV/AIDS and a history of childhood sexual abuse (Journal of Acquired Immune Deficiency Syndromes (2008) 47 (506-513)).
55:286.
2010
-
HIV risk behavior in treatment-seeking opioid-dependent youth: results from a NIDA clinical trials network multisite study..
55:65-72.
2010
-
Microalbuminuria is associated with all-cause and AIDS mortality in women with HIV infection..
55:73-77.
2010
-
Predicting virologic failure among HIV-1-infected children receiving antiretroviral therapy in Tanzania: a cross-sectional study..
54:368-375.
2010
-
Results of the NIMH collaborative HIV/sexually transmitted disease prevention trial of a community popular opinion leader intervention..
54:204-214.
2010
-
Hepatitis C and the risk of kidney disease and mortality in veterans with HIV..
53:222-226.
2010
-
Characteristics of HIV voluntary counseling and testing clients before and during care and treatment scale-up in Moshi, Tanzania..
52:648-654.
2009
-
The differential binding and activity of PRO 2000 against diverse HIV-1 envelopes..
51:125-129.
2009
-
Effect of trimethoprim-sulfamethoxazole prophylaxis on antimicrobial resistance of fecal Escherichia coli in HIV-infected patients in Tanzania..
47:585-591.
2008
-
Effects of a coping intervention on transmission risk behavior among people living with HIV/AIDS and a history of childhood sexual abuse..
47:506-513.
2008
-
Pharmacokinetic effect of AMD070, an Oral CXCR4 antagonist, on CYP3A4 and CYP2D6 substrates midazolam and dextromethorphan in healthy volunteers..
47:559-565.
2008
-
Utilization of mental health and substance abuse care for people living with HIV/AIDS, chronic mental illness, and substance abuse disorders..
47:449-458.
2008
-
The influence of psychosocial characteristics and race/ethnicity on the use, duration, and success of antiretroviral therapy..
47:194-201.
2008
-
False-positivity of HIV-2 immunoblots in a cohort of elite suppressors infected with HIV-1.
47:644-.
2008
-
Inclusion of adolescents in preventive HIV vaccine trials: public health policy and research design at a crossroads..
47:86-92.
2008
-
Lessons from a multisite international trial in the Caribbean and South America of an HIV-1 Canarypox vaccine (ALVAC-HIV vCP1452) with or without boosting with MN rgp120..
46:222-230.
2007
-
Phase 2 study of an HIV-1 canarypox vaccine (vCP1452) alone and in combination with rgp120: negative results fail to trigger a phase 3 correlates trial..
44:203-212.
2007
-
Psychiatric illness and virologic response in patients initiating highly active antiretroviral therapy..
44:159-166.
2007
-
An adenovirus-based HIV subtype B prime/boost vaccine regimen elicits antibodies mediating broad antibody-dependent cellular cytotoxicity against non-subtype B HIV strains..
43:270-277.
2006
-
Long-term results of initial therapy with abacavir and Lamivudine combined with Efavirenz, Amprenavir/Ritonavir, or Stavudine..
43:284-292.
2006
-
Prevalence of DSM-IV-defined mood, anxiety, and substance use disorders in an HIV clinic in the Southeastern United States..
42:298-306.
2006
-
HIV-1 infection initiates an inflammatory cascade in human renal tubular epithelial cells..
42:1-11.
2006
-
Minimizing resistance consequences after virologic failure on initial combination therapy: a systematic overview..
41:323-331.
2006
-
Validation of a brief screening instrument for substance abuse and mental illness in HIV-positive patients..
40:434-444.
2005
-
A community-based study of the incidence of trimethoprim-sulfamethoxazole-preventable infections in Malawian adults living with HIV..
39:626-631.
2005
-
HIV-inducing factor in cervicovaginal secretions is associated with bacterial vaginosis in HIV-1-infected women..
39:340-346.
2005
-
Attenuated poxvirus-based Simian Immunodeficiency Virus (SIV) vaccines given in infancy partially protect infant and juvenile macaques against repeated oral challenge with virulent SIV.
38:124-134.
2005
-
Persistent antiretroviral activity of nucleoside analogues after prolonged zidovudine and lamivudine therapy as demonstrated by rapid loss of activity after discontinuation..
37:1581-1583.
2004
-
Portable colposcopy in low-resource settings..
37 Suppl 3:S167-S170.
2004
-
The impact of race/ethnicity on mother-to-child HIV transmission in the United States in Pediatric AIDS Clinical Trials Group Protocol 316..
36:800-807.
2004
-
Prevalence of chemokine and chemokine receptor polymorphisms in seroprevalent children with symptomatic HIV-1 infection in the United States..
35:309-313.
2004
-
Changes in CD4+ T-cell differentiation phenotype during structured treatment interruption in patients with chronic HIV-1 infection..
34:475-481.
2003
-
Contraception use, family planning, and unprotected sex: few differences among HIV-infected and uninfected postpartum women in four US states..
33:608-613.
2003
-
Predose infant nevirapine concentration with the two-dose intrapartum neonatal nevirapine regimen: association with timing of maternal intrapartum nevirapine dose..
33:153-156.
2003
-
Safety and immunogenicity of a high-titered canarypox vaccine in combination with rgp120 in a diverse population of HIV-1-uninfected adults: AIDS Vaccine Evaluation Group Protocol 022A..
29:254-261.
2002
-
Addressing the challenges of adherence..
29 Suppl 1:S2-10.
2002
-
Estimated global distribution and regional spread of HIV-1 genetic subtypes in the year 2000..
29:184-190.
2002
-
Who will enroll? Predicting participation in a phase II AIDS vaccine trial..
27:281-288.
2001
-
Rationing HIV medications: what do patients and the public think about allocation policies?.
26:56-62.
2001
-
Early detection: the next steps..
25 Suppl 2:S157-S159.
2000
-
Characteristics of hospitalizations of HIV-infected patients: an analysis of data from the 1994 healthcare cost and utilization project..
22:503-508.
1999
-
Seroprevalence of HTLV-I in Cheju Island, a Korean island adjacent to the endemic area of Japan..
22:409-412.
1999
-
Nitric oxide modulates HIV-1 replication..
22:1-9.
1999
-
A-102 Antibody binding to HIV-1 infected cells as mechanism for treatment of HIV infection
2018
-
Randomized Controlled Trial of an Intervention to Maintain Suppression of HIV Viremia After Prison Release: The imPACT Trial.
2017
-
Improving Depression Among HIV-Infected Adults: Transporting the Effect of a Depression Treatment Intervention to Routine Care.
2016
-
D-107 Vaccination establishes CXCR5+PD1+CD4+ peripheral blood germinal center T follicular helper cell relatives in humans
2016
-
E-103 The pathway to HIV vaccine development
2016
-
A-112 DNA and Protein Co-immunization Improves the Magnitude, Longevity, and mucosal dissemination of Immune Responses
2014
-
E-102 Advances in Prophylactic HIV Vaccine Development
2014
-
Analysis of Broad Neutralizing B Cell Lineages to Guide HIV-1 Immunogen Design
2013
-
Comparison of systemic and mucosal responses after DNA and protein co-immunization
2013
-
HIV-1 Vaccine Elicited IgA and IgG Antibody Specificities
2013
-
Identification of Three Distinct Epitope Regions in the V2 Portion of gp120
2013
-
Magnitude, Breadth and Duration of HIV-1 Vaccine-Elicited Neutralizing Antibody Responses
2013
-
114 Role of Vaccine-induced V2 Antibodies in Protection From HIV Infection of Recipients in the RV144 Clinical Vaccine Trial
2012
-
142 HIV Frequently Elicits Mucosal and Plasma Env-Specific IgA With a Rapid Initial Decline In Acute Infection
2009